Log in to your Inderes Free account to see all free content on this page.

Newbury Pharmaceuticals

1.33 SEK

-1.12%

Less than 1K followers

NEWBRY

First North Stockholm

Medical Equipment & Services

Health Care

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Newbury Pharmaceuticals

2024Q1/25Q2/25Q3/25Q4/252025Q1/26Q2/26
Revenue36.86.512.46.75.931.611.78.5
EBITDA-12.3-3.8-1.0-5.7-5.9-16.3-5.5-3.7
EBIT-14.1-4.2-1.4-6.2-10.1-22.0-6.1-4.1
EBIT-%-38.2 %-64.7 %-11.6 %-92.2 %-171.1 %-69.6 %-52.2 %-49.0 %
Profit before taxes-15.4-4.6-1.9-6.6-10.5-23.6-6.5-4.6
Net income-15.4-4.6-1.9-6.6-10.8-23.9-6.5-4.6
Login required

This content is only available for logged in users